Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 1 Distribution of S100A10 status in ovarian cancer according to clinicopathological characteristics

From: S100A10 silencing suppresses proliferation, migration and invasion of ovarian cancer cells and enhances sensitivity to carboplatin

Clinical VariablePatientsS100A10 expression
(No. of cases)
P Value
LowHigh
All cases1386573 
Age at Diagnosis≥6024160.013
< 604553
Residual tumor size (cm)≥219160.557
< 25053
Level of CA125 in primary tumors (U/ml)≥50050550.318
< 5001914
Recurrent typeCarboplatin-sensitive4926< 0.001
Carboplatin-resistant2043
FIGO stageIII57520.296
IV1217
Tumor gradeG1/G229180.048
G34051
  1. NOTE: P value highlighted in bold indicate P < 0.05